Return To Mondaq Homepage Pharmaceutical, Healthcare & Life Sciences
Preview most recent added content
Login
Register for Free
First Time Here?
 
Mondaq Topics
 
Our Services
 
About This Site
 
Advertise with Us
Unsubscribe
Copyright
Welcome to All Regions
Home Page About Search All Regions Browse Site
Your first time here? Click here for a quick guide to our website.

Here you will find the latest thinking on legal, accounting, regulatory and commercial issues supplied by the world's leading professional advisors.

If you are a professional advisor yourself (for example you are part of a law firm, consultancy group or accountancy firm), and your organisation writes articles, please click here.

Below are the lastest articles on Pharmaceutical, Healthcare & Life Sciences from All Regions Briefing. Different topic options are on the left; different regional options are at the top of the page. Alternatively you can search our database for articles by date, topic, firm, country, author, free text, etc.

You are currently viewing content on this site filtered by the topic of Pharmaceutical, Healthcare & Life Sciences. If you would like to remove this filter, click here

Free Personalized News Alerts
Keep up to date with the most recently added articles to Mondaq in accordance with your topic preferences.
>Signup<
Hot Topics Headlines

Top 10 Pharmaceutical, Healthcare & Life Sciences Headlines from All Regions

Failing to comply with various federal group health plan mandates, including COBRA and HIPAA portability, just got riskier and costlier for employers.
On October 9, 2009, CMS issued a proposed rule, Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (Proposed Rule), which establishes new and revised rules for Medicare managed care (Part C), Medicare Advantage (MA), and Medicare prescription drug plans (Part D). CMS will accept comments on the Proposed Rule until December 8, 2009.
The Office for Civil Rights of the Department of Health and Human Services (HHS) recently issued a proposed regulation implementing certain provisions of Title I of the Genetic Information Nondiscrimination Act of 2008 (GINA) that clarifies the status of genetic information as protected health information under the HIPAA Privacy Rule.
New measures for foreign currency loans and foreign currency indexed loans.
Competition authorities continue to examine various aspects of the pharmaceutical industry.
HITECH Act Greatly Expands Scope of HIPAA'sApplicability and Enforcement and Increases Civil MonetaryPenalties for Violations.
Hospitals that look to health reform initiatives for a reduction in their burden of uncompensated care may find that declining compensation for related costs offsets any expected gains.
In whatever form biosimilar legislation might take, patent holders will need to review their patent portfolios carefully.
To sell a medicine in the European Union (EU), a marketing authorisation (MA) is required.
The next chapter in the ongoing effort by the federal government to narrow the permissible uses of personal health information by entities engaged in the health care industry has arrived.
Latest News from Pharmaceutical, Healthcare & Life Sciences
in All Regions
Our most popular article this week:
Health Care Reform: More Aggressive Fraud Enforcement And Broader Government Oversight Are On The Horizon
from Pharmaceutical, Healthcare & Life Sciences
by Fried Frank Harris Shriver & Jacobson
View Recent Headlines Covering    
© Mondaq® 1994-2009.
All Rights Reserved